Older people whose cholesterol levels change over time may be 60% more likely to develop dementia than those whose cholesterol is stable, a study suggests. Researchers tracked almost 10,000 people for ...

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows.

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion ...

HDL cholesterol levels demonstrate a U-shaped association with AMD, in which both high and low levels elevate risk.

There is decreased risk for MACE, stroke, and mortality in patients with newly diagnosed atrial fibrillation who regularly use statins.

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

The prevalence of medical misinformation, worsening physician burnout, and growing competition with medical artificial ...

Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...

A University of Iowa research team has found that a class of cholesterol-lowering drugs have no effect on kidney function.